App-Quantinova.ai

Genetic Variation in the Promoter of the Human Growth Hormone Receptor (GHR) Gene Is Associated with Idiopathic Short Stature (ISS)

Cynthia Gates Goodyer - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Short stature, idiopathic, X-linked

Human growth hormone

Assessment of Aortic Stiffness and Blood Pressure in Young Turner Syndrome Patients

Kristopher T Kang - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Bicuspid aortic valve

N/A

Ovarian "Cloaking" Can Lead to Successful Pregnancies in Women with Premature Ovarian Insufficiency

William Buckett - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Premature ovarian failure

Glucocorticoid

Gonadotropin Releasing Hormone, Kisspeptin, Testosterone and Estradiol Stimulate NUCB2/Nesfatin-1 mRNA Expression in Murine Cells in Vitro in a Dose- and Time-Dependent Manner

Suraj Unniappan - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

Alora

Effect of Testosterone Therapy Combined with a Very Low Caloric Diet on Fat Mass in Obese Men with a Low- to Low-Normal Testosterone Level: A Randomized Controlled Trial

Rudolf Hoermann - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

LPCN 1111

Novel Mutations of POLD1 and WRN Genes in a Case of Adipose Redistribution Syndrome (ARS) Associated with Hypothyroidism

Adam D McIntyre - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Dyslipidemia

Dexamethasone

Development of a Novel, Crispr-Cas9 Derived Mouse Model for Studies of IGSF1 Deficiency Syndrome

Tanya Lynn Rose Silander - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hypothyroidism

N/A

A Challenging Case of Amiodarone-Induced Thyrotoxicosis

Nathalie Saad - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Thyrotoxicosis

Technetium (99mTc) sestamibi

Malignant Ovarian Germ Cell Tumor, Lung Cysts and Multinodular Goitre with Differentiated Thyroid Neoplasm in a Patient with PTEN Hamartoma Tumor Syndrome (PHTS)

Dorothee Bouron-Dal Soglio - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cowden syndrome 1

Arginine hydrochloride

Novel Gene Mutation for Resistance to Thyroid Hormone May be Associated with Atrial Fibrillation

Sawyer Huget-Penner - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Thyroid hormone resistance syndrome

Lyothyronine

Chronic Exposure to EPI-002 May Select for Drug Resistant Clones in Prostate Cancer Via an EPI-Specific Mechanism

Yu Chi Yang - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Metastatic castration-resistant prostate cancer

Enzalutamide

Targeting Androgen-Repressed and Androgen-Induced Genes: Combination Therapy a More Plausible Treatment Conduit for Castration Resistant Prostate Cancer?

Gang Wang - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Metastatic castration-resistant prostate cancer

Enzalutamide

Recommendations for Thyroid Cancer Surveillance Among Survivors of Childhood Cancer: A Report from the International Late Effects of Childhood Cancer Guideline Harmonization Group

Leontien C. Kremer - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Mismatch repair deficiency

MIBG

Neurofibromatosis Type 1-Related Pheochromocytoma: Clinical Characterization of a New Series of 9 Cases

Nada El Ghorayeb - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Neurofibromatosis type 1

Methadone hydrochloride

Biochemical and Physical Function Outcomes in Adolescents and Adults with Hypophosphatasia Treated with Asfotase Alfa for up to 4 Years: Interim Results from a Phase II Study

Katherine L Madson - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypophosphatasia

Alkaline phosphatase

Effects of Denosumab on Bone Mineral Density in Treatment-Naive Patients and Patients Previously Treated with Other Osteoporosis Therapies

Mohammed Almohaya - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

Zoledronic acid

Does Sitagliptin Affect the Rate of Osteoporotic Fractures in Type-2 Diabetes? Population-Based Cohort Study

Robert G Josse - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Thiazolidinedione

Androgens Modulate Plasma and Intestinal Triglyceride and Cholesterol Metabolism in a PCOS-Prone Rodent Model

Spencer Proctor - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Polycystic Ovary Syndrome

Dihydrotestosterone

Does Subclinical Inflammation Compromise Bone Quality in Women with Polycystic Ovary Syndrome?

Millan Patel - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Polycystic Ovary Syndrome

Androgen Tear

Importance of Basal and Post ACTH Aldosterone Levels and Contralateral Aldosterone Suppression during Bilateral Simultaneous Adrenal Venous Sampling in Primary Aldosteronism

Tania L Mazzuco - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Primary aldosteronism

N/A

Filters

28841 Abstracts